Core Viewpoint - MediaAlpha, Inc. is under investigation for potential securities fraud and unlawful business practices, following allegations of deceptive advertising and misleading claims regarding health insurance products [1][4]. Group 1: Allegations and Investigations - Wolfpack Research published a report claiming MediaAlpha engaged in consumer fraud, stating that up to 78% of its health insurance lead-buying partners were involved in scams or legal violations [3]. - The Federal Trade Commission (FTC) indicated it was prepared to file a complaint against MediaAlpha for false representations and misleading claims related to health insurance [4]. - MediaAlpha is settling claims with the FTC for $45 million, with allegations that it misled consumers while collecting personal information for telemarketers [5]. Group 2: Stock Price Impact - Following the Wolfpack Research report, MediaAlpha's stock price dropped by $1.92, or 11.84%, closing at $14.29 per share [3]. - After the FTC's announcement, the stock price fell by $4.46, or 27.7%, closing at $11.62 per share [4].

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud and unlawful business practices involving Soleno Therapeutics, Inc. following a negative report on its product Vykat XR, which led to a significant drop in the company's stock price [1][3]. Group 1: Investigation Details - Pomerantz LLP is representing investors of Soleno Therapeutics, Inc. and is looking into claims of securities fraud or other unlawful practices by the company and its officers [1]. - The investigation was prompted by a report from Scorpion Capital that criticized Soleno's only product, Vykat XR, labeling it as overpriced and potentially unsafe for children [3]. Group 2: Stock Price Impact - Following the release of the Scorpion report on August 15, 2025, Soleno's stock price decreased by $5.73 per share, which is a decline of 7.41%, closing at $71.63 per share on the same day [3]. Group 3: Company Background - Soleno Therapeutics, Inc. is a company that has been under scrutiny due to concerns regarding its product and business practices, which may affect investor confidence and market performance [1][3].

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud and unlawful business practices involving Align Technology, Inc. and its officers or directors, following disappointing financial results and a significant stock price drop [1][3]. Financial Performance - Align Technology reported total revenues of approximately $1.01 billion for Q2 2025, which was below both consensus estimates and the company's own guidance [3]. - The company lowered its revenue guidance for Q3 and full-year growth expectations, attributing this to economic uncertainty and reduced demand for its products [3]. - Following the announcement, Align's stock price fell by $74.56 per share, or 36.63%, closing at $129.01 per share on July 31, 2025 [3]. Legal Investigation - Pomerantz LLP is actively investigating claims on behalf of investors regarding potential securities fraud by Align Technology [1]. - Investors are encouraged to contact Pomerantz LLP for more information about the investigation and potential class action [1].

Core Viewpoint - A class action lawsuit has been filed against Fluor Corporation and certain officers for alleged violations of federal securities laws during the Class Period from February 18, 2025, to July 31, 2025, seeking damages for affected investors [1][2]. Company Overview - Fluor Corporation provides engineering, procurement, and construction (EPC), fabrication and modularization, and project management services globally, operating through three segments: Urban Solutions, Energy Solutions, and Mission Solutions [4]. Financial Performance and Guidance - In February 2025, Fluor projected adjusted EBITDA for FY 2025 to be between $575 million and $675 million, and adjusted EPS between $2.25 and $2.75 per share, which was reaffirmed in May 2025 despite acknowledging potential negative impacts from economic uncertainty [6]. - On August 1, 2025, Fluor reported Q2 2025 results, with non-GAAP EPS of $0.43, missing estimates by $0.13, and revenue of $3.98 billion, a 5.9% year-over-year decline, also missing estimates by $570 million [8]. - The revised financial outlook for FY 2025 was adjusted to an EBITDA of $475 million to $525 million and EPS of $1.95 to $2.15 per share, significantly lower than previous guidance [8]. Allegations and Impact - The lawsuit alleges that Fluor's executives made materially false and misleading statements regarding the company's business and financial health, particularly concerning rising costs in key infrastructure projects and the impact of economic uncertainty on operations [7]. - Following the disappointing Q2 results and disclosures about project issues, Fluor's stock price fell by $15.35 per share, or 27.04%, closing at $41.42 on August 1, 2025 [9].

Core Viewpoint - J.M. Smucker Company is under investigation for potential violations of federal securities laws following significant impairment charges related to its Sweet Baked Snacks segment and the Hostess brand trademark, which have led to a notable decline in stock price [1][3]. Group 1: Company Overview - J.M. Smucker manufactures and markets branded food and beverage products, including the recently acquired Hostess Brands, Inc., which specializes in sweet baked goods [2]. - The company previously claimed that the Hostess acquisition was "highly complementary" and that trends in sweet snacking were favorable [2]. Group 2: Financial Performance - In Q4 2025, J.M. Smucker reported an $867 million impairment charge related to the goodwill of its Sweet Baked Snacks segment and a $113 million impairment charge for the Hostess brand trademark [3]. - Following the announcement of these impairment charges, J.M. Smucker's stock price fell by $17.44 per share, a decrease of over 18%, from $111.85 on June 9, 2025, to $94.41 on June 10, 2025 [3]. Group 3: Legal Implications - The investigation by Bleichmar Fonti & Auld LLP suggests that investors may have legal options available due to the company's financial disclosures and subsequent stock performance [1][4].

Core Viewpoint - BellRing Brands, Inc. is under investigation for potential violations of federal securities laws, with concerns regarding the sustainability of its sales growth driven by temporary trade inventory loading rather than genuine consumer demand [1][2]. Group 1: Company Overview - BellRing Brands operates in the convenient nutrition category, primarily known for its brands Premier Protein and Dymatize, which offer ready-to-drink protein shakes and powders [2]. - The company reported that Premier Protein achieved an all-time high in household penetration, indicating strong demand and growth across all channels due to distribution expansion and promotional activities [2]. Group 2: Sales Growth Concerns - The sales growth during the relevant period may not be sustainable, as it could have been influenced by temporary trade inventory loading at key retailers rather than lasting consumer demand [2]. - On May 5, 2025, BellRing disclosed that several key retailers reduced their weeks of supply, which would negatively impact growth in Q3 2025, leading to a significant stock price drop of over 18% [3]. - Following disappointing quarterly consumption results for Premier Protein RTD Shakes on August 4, 2025, the stock price fell nearly 33%, indicating a misalignment between expected and actual sales performance [4].

Core Viewpoint - A class action lawsuit has been filed against Fly-E Group, Inc. for alleged securities fraud and unlawful business practices, following a significant decline in the company's net revenues attributed to recent lithium-battery accidents involving E-Bikes and E-Scooters [2]. Group 1: Lawsuit Details - The class action lawsuit concerns whether Fly-E and certain officers or directors engaged in securities fraud or other unlawful business practices [2]. - Investors have until November 7, 2025, to request the Court to appoint them as Lead Plaintiff if they purchased Fly-E securities during the Class Period [2]. Group 2: Financial Performance - On August 14, 2025, Fly-E reported a 32% decrease in net revenues for the first quarter of fiscal year 2026, primarily due to a decrease in total units sold [2]. - Following the revenue announcement, Fly-E's stock price plummeted by $6.76 per share, or 87.11%, closing at $1.00 per share on August 15, 2025 [2].

Core Viewpoint - A class action securities lawsuit has been filed against Dow Inc. alleging securities fraud that negatively impacted investors between January 30, 2025, and July 23, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that Dow Inc. overstated its ability to manage macroeconomic and tariff-related challenges, as well as its financial flexibility to support dividends [2]. - It is alleged that the true extent of negative impacts from competitive pressures, declining global sales, and product oversupply was understated [2]. - The defendants' public statements are claimed to have been materially false and misleading throughout the relevant period [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until October 28, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this [3]. - Class members may be entitled to compensation without incurring any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing significant settlements for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

Core Viewpoint - A class action securities lawsuit has been filed against Fiserv, Inc. alleging securities fraud that negatively impacted investors between July 24, 2024, and July 22, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that Fiserv made false statements regarding its Clover platform, which was forced upon Payeezy merchants due to issues with the older platform [2]. - It is alleged that the revenue growth of Clover was artificially inflated by the forced conversions, masking a slowdown in new merchant acquisitions [2]. - Following the conversions, many former Payeezy merchants reportedly switched to competitors due to Clover's high pricing and poor customer service, leading to a significant slowdown in Clover's growth [2]. - The lawsuit asserts that Fiserv's positive statements about Clover's growth strategies and business prospects were materially false and misleading [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified period have until September 22, 2025, to request to be appointed as lead plaintiff in the case [3]. - Participation in the lawsuit does not require any out-of-pocket costs or fees for class members [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [4]. - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Core Points - A class action has been filed against KBR, Inc. for allegedly misleading investors regarding the capabilities of its joint venture, HomeSafe Alliance, in fulfilling a contract with TRANSCOM [1][2] - KBR holds a 72% economic interest in HomeSafe, which was awarded the Global Household Goods Contract by the U.S. Department of Defense [2] - Allegations state that KBR was aware of concerns regarding HomeSafe's ability to meet contract obligations but continued to assure investors that the partnership was functioning well [3] - On June 19, 2025, HomeSafe announced a notice to terminate the contract, leading to a significant drop in KBR's stock price [4] Company Overview - KBR, Inc. provides science, technology, and engineering solutions to governments and companies globally [1] - The company is currently facing legal scrutiny due to the performance issues of its joint venture, HomeSafe, which may impact its reputation and financial standing [2][3] Stock Performance - Following the announcement of the contract termination, KBR's stock price fell by $3.85 (7.29%) to close at $48.93 on June 20, 2025, and further declined by $1.30 (2.65%) to close at $47.63 on June 23, 2025 [4]